AB
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
341.7
Exchange
XNYS - New York Stock Exchange, Inc
13.2 B
Last period Cash and equivalents ,USD
143%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Abbvie
Company Analysis
ABBV valuation, rating, competitors, insights and company profile
Eyestock Rating
ABBV financial analysis by Eyestock methodology
Valuation
ABBV valuation using historical relative method
Statements
ABBV Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ABBV dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Abbvie`s Cash and equivalents for the period ended 2024-06-30 are 13.2 B USD
